

Second Primary Malignancies [see WARNINGS AND.The following clinically significant adverse reactions areĭescribed in detail in other sections of the label: Read the entire detailed patient monograph for Empliciti (Elotuzumab for Injection) cold symptoms such as runny nose or sore throat.numbness, weakness, tingling, or burning pain in your arms or legs.Your cancer treatments may be delayed or permanently discontinued if you have certain side effects. signs of pneumonia-fever, chills, cough with mucus, chest pain, feeling short of breath.
Eloquent medication skin#

Empliciti During Pregnancy and BreastfeedingĮmpliciti is not recommended for use during pregnancy it may harm a fetus. Tell your doctor all medications and supplements you use. What Drugs, Substances, or Supplements Interact with Empliciti? The dose of Empliciti given with lenalidomide and dexamethasone is 10 mg/kg administered intravenously every week for the first two cycles and every 2 weeks thereafter until disease progression or unacceptable toxicity. blood clot in the lungs ( pulmonary embolism), and.Tell your doctor if you have serious side effects of Empliciti including: low white blood cell count (lymphocytopenia), and.tingling or numbness in the hands and feet,.What Are Side Effects for Empliciti?Ĭommon side effects of Empliciti include: Cunha, DO, FACOEPĮmpliciti (elotuzumab) for injection is a SLAMF7-directed immunostimulatory antibody indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received one to three prior therapies.
